Can I continue taking a nitric oxide supplement (e.g., L‑arginine or beetroot juice) while using a phosphodiesterase type 5 inhibitor (PDE5 inhibitor such as sildenafil, tadalafil, or vardenafil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nitric Oxide Supplements Can Be Continued with PDE5 Inhibitors

You can safely continue taking nitric oxide supplements (L-arginine, L-citrulline, or beetroot juice) while using PDE5 inhibitors like sildenafil, tadalafil, or vardenafil. In fact, combining L-arginine with PDE5 inhibitors may enhance erectile function compared to either treatment alone 1.

Key Distinction: Supplements vs. Nitrate Medications

The critical issue is understanding what is absolutely contraindicated versus what is safe:

Absolute Contraindications (Never Use with PDE5i):

  • Organic nitrate medications (nitroglycerin, isosorbide dinitrate, isosorbide mononitrate)
  • Recreational "poppers" (amyl nitrite, butyl nitrite)
  • Guanylate cyclase stimulators (riociguat)

These cause life-threatening hypotension when combined with PDE5 inhibitors 2, 3.

Safe to Use with PDE5i:

  • Nitric oxide precursor supplements (L-arginine, L-citrulline)
  • Dietary nitrates (beetroot juice)
  • Other NO-supporting supplements (resveratrol, alpha-lipoic acid)

Evidence Supporting Combination Therapy

A meta-analysis of randomized controlled trials demonstrated that combining L-arginine with PDE5 inhibitors significantly improved sexual function scores and total testosterone levels compared to either treatment alone (p <0.00001 for both comparisons) 1. Importantly, this combination did not increase adverse events compared to PDE5 inhibitors alone 1.

The mechanism differs fundamentally: organic nitrate medications directly release NO and cause profound vasodilation, while supplements like L-arginine provide substrate for endogenous NO production through the NO synthase pathway 4. This endogenous pathway is self-regulating and does not produce the dangerous synergistic hypotension seen with nitrate medications.

Clinical Monitoring Recommendations

While the combination is safe, patients should:

  • Monitor for enhanced hypotensive effects when first combining supplements with PDE5 inhibitors, particularly if on antihypertensive medications 5
  • Avoid excessive alcohol (>5 drinks), which can compound blood pressure effects 3
  • Report any dizziness, lightheadedness, or syncope immediately

The AUA guidelines emphasize monitoring patients on continuing PDE5 inhibitor therapy for "any significant change in health status including medications" 5, which would include starting new supplements, though NO precursors are not contraindicated.

Common Pitfall to Avoid

Do not confuse nitric oxide supplements with nitrate medications. Pharmacists and patients sometimes mistakenly believe all "nitrate" or "nitric oxide" products are contraindicated with PDE5 inhibitors. The contraindication applies only to organic nitrate vasodilator medications, not to dietary supplements that support endogenous NO production 3, 6.

If you develop angina requiring nitrate medication, you must wait 24 hours after sildenafil or vardenafil and 48 hours after tadalafil before taking nitrates 5.

Related Questions

What is the appropriate pharmacy order and indication for prescribing a PDE‑5 inhibitor for erectile dysfunction in a male patient taking losartan 50 mg daily, ezetimibe, fenofibrate, and atorvastatin 80 mg, with no nitrate use or contraindicating medications?
What are the recommended washout intervals between the last dose of each phosphodiesterase‑5 inhibitor (avanafil, sildenafil, tadalafil) and administration of a nitrate in angina management?
Are phosphodiesterase-5 (PDE-5) inhibitors contraindicated in patients with atrial fibrillation or atrial flutter?
What is the severity of the interaction between tadalafil (phosphodiesterase inhibitor) and sublingual nitroglycerin (nitrate)?
Is it safe for a patient with an implanted cardioverter‑defibrillator (ICD) and stable cardiovascular status, not taking nitrates, to use sildenafil (Viagra)?
Is farming an independent risk factor for spontaneous subarachnoid hemorrhage (SAH)?
In a patient with acute kidney injury (serum creatinine 2.28 mg/dL), which of the following medications should be stopped: gliclazide 60 mg once daily, valsartan 160 mg plus hydrochlorothiazide 12.5 mg once daily, carvedilol 25 mg twice daily, sitagliptin 50 mg plus metformin 1 g once daily, aspirin 80 mg once daily, dapagliflozin 10 mg once daily, atorvastatin 40 mg once daily, and pregabalin 75 mg at bedtime?
What is the risk of antidepressant-induced mood switching in patients with bipolar disorder, and how should it be managed?
What is the summary and pharmacokinetic profile of cariprazine, including its mechanism of action, approved indications, dosing, metabolism, and relevant drug interactions?
What is the recommended management and chemotherapy regimen for telangiectatic osteosarcoma in adolescents and young adults?
What is the appropriate treatment for scabies in a 3½‑year‑old girl?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.